Skip to main content
. Author manuscript; available in PMC: 2022 Jul 19.
Published in final edited form as: Exp Dermatol. 2021 Nov 7;31(3):384–392. doi: 10.1111/exd.14484

Figure 1.

Figure 1.

The two main methods for developing and applying 3D bioprinted therapies are in situ and in vitro. This figure displays both processes from initial cell culture to final patient application (created with BioRender.com).